Cephalon raises guidance again after new products launch well
This article was originally published in Scrip
Executive Summary
Cephalonhas again raised its revenue outlook for 2008 after another strong performance in the second quarter. The company's sales beat its own guidance of $455-465 million, increasingby 11% to $485 million compared with the second quarter of last year.